In a challenging market environment, Hemispherx Biopharma Inc (NYSE:AIM), trading under the ticker AIM, has seen its stock price touch a 52-week low, reaching a sobering $0.13, marking an 82% decline ...

For example, quote pages like this one allows you to chart a stock's progress, examine in-depth financials, read its latest announcements and much more to help you make informed decisions.

TTD stock has gained 70% since the start of 2024, significantly outperforming the S&P 500, which has risen by 27% over the ...

Investors are braced for more Trump tariffs as focus turns to inflation and Fed Chair Jerome Powell's Senate testimony.

Have you ever wondered about the continuous display of stock price on a financial news channel or the ribbon of stock prices on major stock exchanges of the world? Ticker tape is even displayed in ...

By the end of February, the company will furnish its 2024 annual report. Besides the revenues, earnings, cash flow, and other ...